Cheng R - Search Results

1

Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis.

Park JO, Ryoo BY, Yen CJ, Kudo M, Yang L, Abada PB, Cheng R, Orlando M, Zhu AX, Okusaka T. Park JO, et al. Among authors: cheng r. Oncotarget. 2016 Nov 15;7(46):75482-75491. doi: 10.18632/oncotarget.12780. Oncotarget. 2016. PMID: 27776351 Free PMC article.

2

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial.

Urba S, Hong RL, Hossain AM, Cheng R, Orlando M. Urba S, et al. Among authors: cheng r. Asia Pac J Clin Oncol. 2013 Dec;9(4):331-41. doi: 10.1111/ajco.12060. Epub 2013 Feb 26. Asia Pac J Clin Oncol. 2013. PMID: 23442047 Free article. Clinical Trial.

3

Elderly subset analysis of randomized phase III study comparing pemetrexed plus carboplatin with docetaxel plus carboplatin as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer.

Pereira JR, Cheng R, Orlando M, Kim JH, Barraclough H. Pereira JR, et al. Among authors: cheng r. Drugs R D. 2013 Dec;13(4):289-96. doi: 10.1007/s40268-013-0032-6. Drugs R D. 2013. PMID: 24277116 Free PMC article. Clinical Trial.

4

Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT.

Yang JC, Ahn MJ, Nakagawa K, Tamura T, Barraclough H, Enatsu S, Cheng R, Orlando M. Yang JC, et al. Among authors: cheng r. Cancer Res Treat. 2015 Jul;47(3):424-35. doi: 10.4143/crt.2013.266. Epub 2014 Sep 15. Cancer Res Treat. 2015. PMID: 25410761 Free PMC article.

5

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned.

Lee DH, Srimuninnimit V, Cheng R, Wang X, Orlando M. Lee DH, et al. Among authors: cheng r. Cancer Res Treat. 2015 Oct;47(4):549-54. doi: 10.4143/crt.2014.362. Epub 2015 Apr 29. Cancer Res Treat. 2015. PMID: 25943319 Free PMC article. Review.

6

Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer.

Muro K, Oh SC, Shimada Y, Lee KW, Yen CJ, Chao Y, Cho JY, Cheng R, Carlesi R, Chandrawansa K, Orlando M, Ohtsu A. Muro K, et al. Among authors: cheng r. J Gastroenterol Hepatol. 2016 Mar;31(3):581-9. doi: 10.1111/jgh.13153. J Gastroenterol Hepatol. 2016. PMID: 26317322 Clinical Trial.

7

Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review.

Chen LT, Oh DY, Ryu MH, Yeh KH, Yeo W, Carlesi R, Cheng R, Kim J, Orlando M, Kang YK. Chen LT, et al. Among authors: cheng r. Cancer Res Treat. 2017 Oct;49(4):851-868. doi: 10.4143/crt.2016.176. Epub 2017 Jan 3. Cancer Res Treat. 2017. PMID: 28052652 Free PMC article. Review.

8

Exposure-response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.

Kim TY, Yen CJ, Al-Batran SE, Ferry D, Gao L, Hsu Y, Cheng R, Orlando M, Ohtsu A. Kim TY, et al. Among authors: cheng r. Gastric Cancer. 2018 Mar;21(2):276-284. doi: 10.1007/s10120-017-0737-2. Epub 2017 Jun 20. Gastric Cancer. 2018. PMID: 28634748 Clinical Trial.

9

Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW.

Muro K, Cho JY, Bodoky G, Goswami C, Chao Y, Dos Santos LV, Shimada Y, Topuzov E, Van Cutsem E, Tabernero J, Zalcberg J, Chau I, Cascinu S, Cheng R, Hsu Y, Emig M, Orlando M, Fuchs C. Muro K, et al. Among authors: cheng r. J Gastroenterol Hepatol. 2018 Apr;33(4):814-824. doi: 10.1111/jgh.14007. Epub 2018 Feb 1. J Gastroenterol Hepatol. 2018. PMID: 28960444

10

Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer.

Chung HC, Kok VC, Cheng R, Hsu Y, Orlando M, Fuchs C, Cho JY. Chung HC, et al. Among authors: cheng r. Asia Pac J Clin Oncol. 2018 Jun;14(3):204-209. doi: 10.1111/ajco.12829. Epub 2018 Jan 10. Asia Pac J Clin Oncol. 2018. PMID: 29318751 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,520 results

Search Page

Filters